Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-29 01:38:43 - browse：612

The corporate offices of Massachusetts General Brigham hospitals in Assembly Square in Somerville. Lane Turner/Globe Staff

The severing of ties between two of Boston’s biggest health care giants has placed one of the nation’s largest health care systems in the position of figuring out how, exactly, to fill a new hole in its oncology services, at a time when cancer care is changing rapidly.

Earlier this month, Dana-Farber Cancer Institute surprised the medical community and even its partner, Brigham and Women’s Hospital, when it announced that it would end their nearly 30-year collaboration. The split will take a few years to play out — Dana-Farber and Brigham and Women’s have a contract into 2028 — but has shaken patients and physicians.

Anne Klibanski, chief executive of Brigham and Women’s parent organization, Mass General Brigham, placed the blame on Dana-Farber executives. The two parties had been in discussions about extending their contract for months when the split was announced. “The decision was made by the Farber. It was announced. Now, we just have to plan forward,” she said. Klibanski shared her views on the split at a meeting with Boston Globe opinion editors on Thursday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Fauci’s Covid grilling leads GOP to weigh foreign research rules

WSS

Generative AI mines health records to identify patients’ social needs

Some top drug companies are starting to take action on climate

WHO recommends second malaria vaccine

Generative AI mines health records to identify patients’ social needs

JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

Generative AI mines health records to identify patients’ social needs

focus

Wikipedia

focus

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The stability of $0 premiums in Medicare Advantage

Psychedelics group wrestles with new pharma identity

The Karikó problem: Lessons for funding basic research

Alkermes shareholders re

What we owe ALS patients — and why one company fell short

Medicare proposal to cover medical devices draws a mixed reaction

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

New air purifier tech could be key to improving indoor air quality

Setback for rare diseases as Taysha Gene Therapies pulls back

focus

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

With Roe v Wade overturned, abortion providers work to adapt

European officials brace for rough respiratory virus season

Doulas covered by Medicaid under New York's new plan

New menopause drug shows promise in relief for hot flashes

Fauci’s Covid grilling leads GOP to weigh foreign research rules

focus

hotspot

focus

Wikipedia